• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4598790)   Today's Articles (9770)   Subscriber (49356)
For: Atzori L, Pinna AL, Pau M, Aste N, Zucca M, Ferreli C. Adverse Cutaneous Reactions to Selective Cyclooxygenase 2 Inhibitors: Experience of an Italian Drug-Surveillance Center. J Cutan Med Surg 2016;10:31-5. [PMID: 17241570 DOI: 10.1007/7140.2006.00012] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Number Cited by Other Article(s)
1
Perks A, Bates TJ, Velangi S, Brown RM, Poveda-Gallego A. Probable etoricoxib-induced fixed drug eruption involving the oral mucosa: A case report. Oral Surg Oral Med Oral Pathol Oral Radiol 2020;131:e100-e107. [PMID: 33468439 DOI: 10.1016/j.oooo.2020.12.019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2020] [Revised: 12/18/2020] [Accepted: 12/18/2020] [Indexed: 11/15/2022]
2
Edel J, Vered M, Grinstein-Koren O, Porat D, Lukach L, Pettesh J, Kelner A, Ianculovici C, Kaplan I. Oral adverse reactions associated with etoricoxib, a common pain medication. J Am Dent Assoc 2019;150:556-561. [DOI: 10.1016/j.adaj.2019.01.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2018] [Revised: 12/25/2018] [Accepted: 01/09/2019] [Indexed: 10/26/2022]
3
Bullous Reactions Associated With COX-2 Inhibitors. Am J Ther 2018;24:e477-e480. [PMID: 28282308 DOI: 10.1097/mjt.0000000000000569] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
4
Patanè M, Isola S, Gangemi S, Minciullo PL. Mucosal exfoliation as a selective reaction to etoricoxib. J Clin Pharm Ther 2016;41:722-724. [DOI: 10.1111/jcpt.12445] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2016] [Accepted: 08/05/2016] [Indexed: 11/28/2022]
5
Andrade P, Gonçalo M. Fixed drug eruption caused by etoricoxib - 2 cases confirmed by patch testing. Contact Dermatitis 2011;64:118-20. [DOI: 10.1111/j.1600-0536.2010.01847.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
6
Calistru AM, Cunha AP, Nogueira A, Azevedo F. Etoricoxib-induced fixed drug eruption with positive lesional patch tests. Cutan Ocul Toxicol 2010;30:154-6. [DOI: 10.3109/15569527.2010.521226] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
7
Leeyaphan C, Kulthanan K, Jongjarearnprasert K, Dhana N. Drug-induced angioedema without urticaria: prevalence and clinical features. J Eur Acad Dermatol Venereol 2009;24:685-91. [PMID: 19925599 DOI: 10.1111/j.1468-3083.2009.03489.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
8
Selective immediate hypersensitivity reactions to NSAIDs. Curr Opin Allergy Clin Immunol 2009;9:293-7. [DOI: 10.1097/aci.0b013e32832db943] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
9
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiol Drug Saf 2008. [DOI: 10.1002/pds.1483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA